bioRxivImmunologyPreprint
SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron
A. Tarke, C. H. Coelho, Z. Zhang, J. M. Dan, E. D. Yu, N. Methot, N. I. Bloom, B. Goodwin, E. Phillips, S. Mallal, J. Sidney, G. Filaci, D. Weiskopf, R. da Silva Antunes, S. Crotty, A. Grifoni, A. Sette
Abstract
We address whether T cell responses induced by different vaccine platforms (mRNA-1273, BNT162b2, Ad26.COV2.S, NVX-CoV2373) cross-recognize SARS-CoV-2 variants. Preservation of at least 83% and 85% for CD4+ and CD8+ T cell responses was found, respectively, regardless of vaccine platform or variants analyzed. By contrast, highly significant decreases were observed for memory B cell and neutralizing antibody recognition of variants. Bioinformatic analyses showed full conservation of 91% and 94% of class II and class I spike epitopes. For Omicron, 72% of class II and 86% of class I epitopes were fully conserved, and 84% and 85% of CD4+ and CD8+ T cell responses were preserved. In-depth epitope repertoire analysis showed a median of 11 and 10 spike epitopes recognized by CD4+ and CD8+ T cells from vaccinees. Functional preservation of the majority of the T cell responses may play an important role as a second-level defense against diverse variants.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, … Constantino III Roberto López-Macías·bioRxiv·Feb 16, 2022
- T cell response following anti COVID-19 BNT162b2 vaccination is maintained against the SARS-CoV-2 Omicron B.1.1.529 variant of concern
H. Cohen, S. Rotem, … E. Bar-Haim·bioRxiv·Jan 19, 2022
- SARS -CoV-2 T-cell immunity to variants of concern following vaccination
K. M. E. Gallagher, M. B. Leick, … M. V. Maus·bioRxiv·May 3, 2021
- Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and efficacy to the Omicron variant.
S. Mise-Omata, M. Ikeda, … A. Yoshimura·bioRxiv·Jul 31, 2022
- Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individuals.
L. De Marco, S. D'Orso, … G. Borsellino·bioRxiv·Dec 30, 2021
- mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern
R. R. Goel, M. M. Painter, … Set·bioRxiv·Aug 23, 2021